HER3 targeting of adenovirus by fiber modification increases infection of breast cancer cells in vitro, but not following intratumoral injection in mice

Treatment of chemotherapy resistant ovarian cancer with a MDR1 targeted oncolytic adenovirus

(2011) Daniel T. Rein et al.   GYNECOLOGIC ONCOLOGY

Direct Binding of the EGF-like Domain of Neuregulin-1 to Integrins (αvβ3 and α6β4) Is Involved in Neuregulin-1/ErbB Signaling

(2010) Katsuaki Ieguchi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Retargeting of Adenovirus Vectors through Genetic Fusion of a Single-Chain or Single-Domain Antibody to Capsid Protein IX

(2010) K. L. Poulin et al.   JOURNAL OF VIROLOGY

Advancements in adenoviral based virotherapy for ovarian cancer

(2009) Kellie S. Matthews et al.   ADVANCED DRUG DELIVERY REVIEWS

The ERBB3 receptor in cancer and cancer gene therapy

(2008) G Sithanandam et al.   CANCER GENE THERAPY

The status and role of ErbB receptors in human cancer

(2008) I. Überall et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Oncolytic adenovirus Ad5/3-Δ24 and chemotherapy for treatment of orthotopic ovarian cancer

(2007) Mari Raki et al.   GYNECOLOGIC ONCOLOGY